Spots Global Cancer Trial Database for Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking

Official Title: Randomized Trial of a Smartphone Application to Help Cancer Patients Stop Smoking (Quit2Heal)

Study ID: NCT04409236

Conditions

Hematopoietic and Lymphoid System Neoplasm

Malignant Solid Neoplasm

Interventions

Quit2Heal

QuitGuide

Survey Administration

Study Description

Brief Summary: This phase III trial compares the Quit2Heal smoking cessation smartphone application (app) to the QuitGuide app in helping cancer patients quit smoking. Both apps provide tools to cope with urges to smoke, step-by-step guides for quitting smoking, help in planning for quitting and staying tobacco-free, and scientifically-based recommendations for how to select medications that aid in smoking cessation.

Detailed Description: OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients receive the Quit2Heal app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it. ARM II: Patients receive the QuitGuide app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it. After randomization, patients are followed up at 3, 6, and 12 months.